A Run With a Mission

More than 1,500 attendees rose early on a beautiful Sunday morning in Orlando to participate in the 2019 ASH Foundation Run/Walk. ASH is pleased to announce that this year’s sponsors, runners, walkers, and all of their supporters helped the Foun dation raise a total...

The Road to Wisdom: ASH-ASPHO Pediatric Choosing Wisely Collaboration

“We are made wise not by the recollection of our past, but by the responsibility for our future.”  - George Bernard Shaw The Choosing Wisely® campaign is an effort led by the American Board of Internal Medicine (ABIM) to support and engage physicians in improving...

Cutting Costs for CML Abroad

Cutting Costs for CML Abroad

“If you have to get cancer,” I once reassured a frightened patient, “CML [chronic myeloid leukemia] isn’t bad.” CML is truly one of our cancer success stories. The identification of a single genetic swap — BCR-ABL — and the development of tyrosine kinase inhibitors...

Constructing an Idea: From Wings to Landing Gear

“Great ideas need landing gear as well as wings.” — Charles Douglas Jackson In the Special-Interest Session, Systems-Based Hematology: How to Implement Evidence-Based Programs for Virtual Hematology Consults and Anticoagulation Stewardship, Michal Rose, MD, and Jean...

Welcome to Orlando

Welcome to Orlando

The Hebrew word for it is hrh. The Hindus speak of prabodhan. In Chinese, it’s qishi. The teachings of Buddhism discuss bodhi ... keihatsu in Japanese. The French use eclaircissement. In my native language, Urdu, it is agahi. In English, the term is enlightenment — an...

Blood Welcomes New Editions to the International Roster

After the uniquely positive experiences following the launch of the initial local language editions of Blood in Italy, Spain, and Latin America, we are delighted to announce that two new editions are being added to the international family of journals: Chinese Blood...

Spotlight on Global Capacity Building

The Global Capacity-Building Showcase (Hall B, Level 2 [Orange County Convention Center] - map it ) is an annual meeting poster category designed to encourage international collaborations in the form of capacity-building programs in low- and middle-income countries....

Update on Precision Medicine Initiatives

Applying the principles of precision medicine to hematologic diseases is a priority for ASH. Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of...

Special Sessions Offer Inside Look at Peer Review

This year’s meeting will offer two Special-Interest Sessions tailored for all those who have an interest in learning more about both sides of the peer review process. First Editor-in-Chief of Blood Bob Löwenberg, MD, PhD, will lead the discussion “How to Get Published...

Supporting Hematology’s Future: ASH Scholar Award Alums

The ASH Scholar Award is the Society’s longest-standing award program and one of the most highly regarded. For almost three decades, ASH has supported hundreds of fellows and junior faculty in both basic and clinical/translational research by providing partial salary...

Meaningful Outreach Knows No Borders

Meaningful Outreach Knows No Borders

Now entering its third cycle, the ASH Global Research Award was created especially for trainees and early- career investigators based in countries outside of the United States and Canada. It is intended to support these hematologists during the critical period between...

The Cure Sickle Cell Initiative: Rewriting an Old Story

The Cure Sickle Cell Initiative: Rewriting an Old Story

The Cure Sickle Cell Initiative (CureSCi; ) was created by the National Heart, Lung, and Blood Institute to accelerate the development of treatments aimed at a genetic- based cure for sickle cell disease (SCD), and ASH has partnered with the Initiative in an effort to...

ASH Clinical Practice Guidelines Update

ASH has long recognized the need for comprehensive guidelines and in the past three years has broken ground on developing and/or updating guidelines on several disease types, including venous thromboembolism (VTE), immune thrombocytopenia (ITP), acute myeloid leukemia...

Update on ASH Immunotherapies Initiatives

The field of immunotherapy has generated novel immune-based strategies and improved the utility of existing treatment options for various hematologic diseases. As such, ASH has had an enduring interest in improving immunotherapies for all hematologic diseases. This is...

ASH Research Collaborative Data Hub

The Data Hub, a component of the recently launched ASH Research Collaborative (ASH RC), is a technology platform that facilitates the exchange of information by aggregating research-grade data on hematologic diseases in one place and making it available for inquiry....

ASH Announces Election of Three to Executive Committee

ASH recently announced the election of three new members to its Executive Committee, the governing body of the organization, for terms beginning after the annual meeting. Jane Winter, MD, will serve a one-year term as vice president followed by successive terms as...

ASH Clinical News Celebrates Its Wooden Anniversary

ASH Clinical News Celebrates Its Wooden Anniversary

Yes, there is such a thing. Traditional gifts include wooden picture frames, baskets, and trees. (If you’ve been together with your partner for longer than five years, perhaps you owe him or her a tree.) Silver and gold milestones may be better known, but wood...

CRTI Expands to Serve Trainees in Asia-Pacific Region

The ASH Clinical Research Training Institute (CRTI) has the goal of improving the training of clinicians in patient-oriented clinical research. With the growth of the program, there has been ongoing interest in disseminating the training program to areas outside of...

Going Strong: Blood Advances Turns Three

Going Strong: Blood Advances Turns Three

The 2019 ASH Annual Meeting marks the third anniversary of Blood Advances — the online, peer-reviewed journal published by ASH. The journal continues to grow to new heights, receiving more submissions and publishing more papers each year. We thank all of our authors, reviewers, editors, and readers for making this possible.

Understanding Equity, Diversity, and Inclusion in Hematology

The ASH Women in Hematology Working Group invites you to attend a thought-provoking, interactive lecture and reception that looks to recognize the value and impact of women in our field. Julie K. Silver, MD, of Harvard Medical School, will be speaking on Accelerating...

ASH Practice Partnership Lunch Spotlights Genomic/Genetic Testing

The ASH Practice Partnership is the Society’s network of practice-based hematologists with interests in practice-related policies, quality of care, new health care delivery systems, and practice management issues. The ASH Practice Partnership Lunch is a special...

Debuting in 2020: Blood Podcast Series

Debuting in 2020: Blood Podcast Series

The editors of Blood are pleased to introduce a new series of podcasts, published weekly in conjunction with each issue of Blood. The new series will highlight selected articles from every issue, and the first promotional podcast will be made available during this...

National Partner Society Abstract Achievement Awards

The National Partner Society Abstract Achievement Awards consist of a $2,000 grant awarded to an international hematologist, who must be a member of the supporting organization and resident of the respective country, to help advance knowledge and inspire continued...

ASH Congratulates the 2019 MRHAP Winners

In 2018 ASH announced an entirely new program for under-represented minority residents, the ASH Minority Resident Hematology Award Program (MRHAP), the goal of which is to provide support for under-represented minority residents to conduct hematology-focused research...

ASH Congratulates the 2019 MMSAP Participants

ASH Congratulates the 2019 MMSAP Participants

Since 2004, the ASH Minority Medical Student Award Program (MMSAP) has provided under-represented minority medical students with an opportunity to engage in an eight-to-12-week hematology-related research project under the guidance of an ASH member. In 2016 the...

ASH Newborn Screening Initiative and Consortium

In an effort to raise awareness of sickle cell disease (SCD) globally by partnering with international organizations to expand SCD-focused education, ASH is exploring the development of a Consortium of African countries to address newborn screening for SCD. The...

A One-of-a-Kind “How I Treat” Experience

Hearing the words “How I Treat” might stir up a diverse array of concepts for hematologists. It can refer to both the popular compendium series of Blood articles as well as the format of talks given at the ASH Meeting on Hematologic Malignancies, but it is always...

With Diversity As a Priority, Everyone Wins

With Diversity As a Priority, Everyone Wins

Griffin Rodgers, MD, of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is awarded the 2019 ASH Award for Leadership in Promoting Diversity. Dr. Rodgers earned the prestigious recognition for his ongoing work on behalf of under-represented...

How to Equip Yourself for Advocacy

How to Equip Yourself for Advocacy

If you are plugged into ASH member communications such as NewsLink or the “Headlines From Washington” column in The Hematologist, you know that your U.S. colleagues are always keeping busy on the advocacy front. For years ASH has been at the foreground of influencing...

New This Year: Trials in Progress

New This Year: Trials in Progress

New this year, abstracts describing innovative Trials in Progress (TiPs; i.e., trials that have not reached the primary endpoint) will be presented at this year’s ASH annual meeting. TiP abstracts are expected to provide investigators with opportunities to discuss...

Meet the Blood Editors

The “Meet the Blood Editor” sessions provide attendees the opportunity to meet with the associate editors of Blood and discuss recent changes to the journal as well as submission and peer-review processes and policies. Seating for the hour-long session is limited and...

Share This